David Orchard-Webb, PhD

337 POSTS 0 COMMENTS
David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.

BC Platforms And Blueprint Genetics Partner To Enable Precision Medicine In Rare Diseases

BC Platforms, a world leader in genomic data management and analytics, has formed a collaboration with Blueprint Genetics, a leader in the field of...

MIMETAS And Hubrecht Organoid Technologies Partner To Market Organoids-On-A-Chip

MIMETAS and Hubrecht Organoid Technologies (HUB) have entered into a strategic collaboration to market organoid models on a Chip. The agreement includes a license...

Abzena Launches ADC and Biologics Cascade Ex-Vivo platforms Augmented With Biobank Samples

Abzena, the leading biologics target to GMP Partner Research Organisation, has augmented its antibody drug conjugation (ADC) and biologics (including mono and bispecific antibodies)...

CureDuchenne Launches Duchenne Muscular Dystrophy Biobank

CureDuchenne, a global leader in research, patient care, and innovation in improving and extending the lives of those living with Duchenne muscular dystrophy (Duchenne),...

Fauna Bio Awarded Phase I Small Business Innovation Research (SBIR) Grant

Fauna Bio Inc., a biotechnology company leveraging the science of evolution and comparative genomics to discover new treatments for human diseases, has been awarded...

Mallinckrodt’s Cryopreserved StrataGraft Makes Phase III Progress Treating Thermal Burns

Mallinckrodt plc, a global biopharmaceutical company, has announced positive top-line results from its pivotal Phase 3 clinical trial of its investigational StrataGraft® regenerative tissue....

Preventice Solutions’ BodyGuardian® MINI Remote Cardiac Monitor Selected For UK Biobank Study

Preventice Solutions has received a tender from the UK Biobank to provide the BodyGuardian® MINI remote cardiac monitor for a cardiovascular monitoring study involving...

Bay Area Lyme Foundation Supports Tick-Borne Disease Conference At Stanford

A grant from Bay Area Lyme Foundation has subsidized the cost of the first tick-borne disease program of the Stanford Centre for Continuing Medical...

Personalis Ramps Up Services To The VA’s Million Veteran Program

Personalis, Inc., a leader in advanced genomics for cancer, has received a new task order under its contract with the U.S. Department of Veterans...

BioLife Backs Startups Specializing In Technology For Cell And Gene Therapy Bioproduction

BioLife Solutions, Inc., a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies has announced a co-investment accelerator program with...

Autoscribe Informatics Welcomes Challenges At Lab Innovations In The NEC

Autoscribe Informatics, known for its highly configurable LIMS solutions, will be putting the latest version of Matrix Gemini LIMS through its paces at Lab...

iSpecimen Marketplace® Expands Access To Hematopoietic Stem And Immune Cells

iSpecimen, devoted to supporting life science researchers who urgently pursue breakthroughs, has partnered with new providers of diseased and healthy hematologic tissue to offer...

ThermoGenesis X-Series® System Performance Validations Reported At Scientific Meetings

Cesca Therapeutics Inc., a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned...

Talking Microbiome At College Of American Pathologists’ Annual Meeting

Pathologists are increasingly optimistic about the potential of the human microbiome to help guide diagnosis and monitoring of chronic diseases. The microbiome includes a...

Pharmaceutical Product Development, LLC Expanding Bioanalytical Laboratory In Richmond

Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing...

🔉 Stay Connected

838FollowersFollow

🔥 Most Popular

X